Cargando…

Persistent post-traumatic headache: a migrainous loop or not? The preclinical evidence

BACKGROUND: According to the International Classification of Headache Disorders 3, post-traumatic headache (PTH) attributed to traumatic brain injury (TBI) is a secondary headache reported to have developed within 7 days from head injury, regaining consciousness following the head injury, or discont...

Descripción completa

Detalles Bibliográficos
Autores principales:	Benemei, Silvia, Labastida-Ramírez, Alejandro, Abramova, Ekaterina, Brunelli, Nicoletta, Caronna, Edoardo, Diana, Paola, Gapeshin, Roman, Hofacker, Maxi Dana, Maestrini, Ilaria, Pías, Enrique Martínez, Mikulenka, Petr, Tikhonova, Olga, Martelletti, Paolo, MaassenVanDenBrink, Antoinette
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Milan 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7362418/ https://www.ncbi.nlm.nih.gov/pubmed/32664898 http://dx.doi.org/10.1186/s10194-020-01135-0

Ejemplares similares

Persistent post-traumatic headache: a migrainous loop or not? The clinical evidence
por: Labastida-Ramírez, Alejandro, et al.
Publicado: (2020)

Position Paper on Post-Traumatic Headache: The Relationship Between Head Trauma, Stress Disorder, and Migraine
por: Lambru, Giorgio, et al.
Publicado: (2020)

Gender aspects of CGRP in migraine
por: Labastida-Ramírez, Alejandro, et al.
Publicado: (2017)

Headache medication and the COVID-19 pandemic
por: MaassenVanDenBrink, Antoinette, et al.
Publicado: (2020)

Clinical symptoms of androgen deficiency in men with migraine or cluster headache: a cross-sectional cohort study
por: Verhagen, Iris E., et al.
Publicado: (2021)

Correction to: Clinical symptoms of androgen deficiency in men with migraine or cluster headache: a cross-sectional cohort study
por: Verhagen, Iris E., et al.
Publicado: (2021)

The potential danger of blocking CGRP for treating migraine in CADASIL patients
por: de Boer, Irene, et al.
Publicado: (2020)

Migraine and cluster headache – the common link
por: Vollesen, Anne Luise, et al.
Publicado: (2018)

European headache federation consensus on the definition of resistant and refractory migraine: Developed with the endorsement of the European Migraine & Headache Alliance (EMHA)
por: Sacco, Simona, et al.
Publicado: (2020)

Metabolic Aspects of Migraine: Association With Obesity and Diabetes Mellitus
por: Rivera-Mancilla, Eduardo, et al.
Publicado: (2021)

Revisiting dose-finding of monoclonal antibodies in migraine
por: Al-Hassany, Linda, et al.
Publicado: (2023)

Burden and attitude to resistant and refractory migraine: a survey from the European Headache Federation with the endorsement of the European Migraine & Headache Alliance
por: Sacco, Simona, et al.
Publicado: (2021)

Giving Researchers a Headache – Sex and Gender Differences in Migraine
por: Al-Hassany, Linda, et al.
Publicado: (2020)

Comparison of the vasodilator responses of isolated human and rat middle meningeal arteries to migraine related compounds
por: Grände, Gustaf, et al.
Publicado: (2014)

Calcitonin gene-related peptide (receptor) antibodies: an exciting avenue for migraine treatment
por: MaassenVanDenBrink, Antoinette, et al.
Publicado: (2018)

Jealousy in women with migraine: a cross-sectional case-control study
por: van Casteren, Daphne S., et al.
Publicado: (2020)

Pain perception in women with menstrually-related migraine
por: Linstra, Katie M, et al.
Publicado: (2020)

Sex differences in prevalence of migraine trigger factors: A cross-sectional study
por: van Casteren, Daphne S, et al.
Publicado: (2020)

Serum CGRP in migraine patients using erenumab as preventive treatment
por: de Vries Lentsch, Simone, et al.
Publicado: (2022)

Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC)
por: Sacco, Simona, et al.
Publicado: (2017)

European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention – 2022 update
por: Sacco, Simona, et al.
Publicado: (2022)

Correction to: Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC)
por: Sacco, Simona, et al.
Publicado: (2018)

Validation of diagnostic ICHD-3 criteria for menstrual migraine
por: Verhagen, Iris E, et al.
Publicado: (2022)

European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention—part 2: flunarizine
por: Deligianni, Christina I., et al.
Publicado: (2023)

PACAP38 and PAC(1) receptor blockade: a new target for headache?
por: Rubio-Beltrán, Eloisa, et al.
Publicado: (2018)

Measurements of 17β-estradiol levels in mice for migraine research
por: Chan, K, et al.
Publicado: (2013)

Characterization of the trigeminovascular actions of several adenosine A(2A) receptor antagonists in an in vivo rat model of migraine
por: Haanes, Kristian A., et al.
Publicado: (2018)

Extracranial Trigger Site Surgery for Migraine: A Systematic Review With Meta-Analysis on Elimination of Headache Symptoms
por: Vincent, Arnaud J. P. E., et al.
Publicado: (2019)

European Headache Federation (EHF) critical reappraisal and meta-analysis of oral drugs in migraine prevention – part 3: topiramate
por: Raffaelli, Bianca, et al.
Publicado: (2023)

The need for new acutely acting antimigraine drugs: moving safely outside acute medication overuse
por: van Hoogstraten, Willem Sebastiaan, et al.
Publicado: (2019)

European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention—part 1: amitriptyline
por: Lampl, Christian, et al.
Publicado: (2023)

Comparing Perimenstrual and Nonperimenstrual Migraine Attacks Using an e-Diary
por: van Casteren, Daphne S., et al.
Publicado: (2021)

Pharmacological analysis of the increases in heart rate and diastolic blood pressure produced by (S)-isometheptene and (R)-isometheptene in pithed rats
por: Labastida-Ramírez, Alejandro, et al.
Publicado: (2017)

Effect of exogenous estrogens and progestogens on the course of migraine during reproductive age: a consensus statement by the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESCRH)
por: Sacco, Simona, et al.
Publicado: (2018)

17β-estradiol and methylation of migraine-related genes
por: Labruijere, S, et al.
Publicado: (2013)

European Headache Federation (EHF) consensus on the definition of effective treatment of a migraine attack and of triptan failure
por: Sacco, Simona, et al.
Publicado: (2022)

Methylation of Migraine-Related Genes in Different Tissues of the Rat
por: Labruijere, Sieneke, et al.
Publicado: (2014)

E-diary use in clinical headache practice: A prospective observational study
por: van Casteren, Daphne S, et al.
Publicado: (2021)

Chronic migraine plus medication overuse headache: two entities or not?
por: Negro, Andrea, et al.
Publicado: (2011)

Comment on “A second trigeminal CGRP receptor: function and expression of the AMY1 receptor”
por: Haanes, Kristian Agmund, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_c2m7q49qvt5u3iou1igegitp1q